MOUNTAIN VIEW, Calif., May 24, 2017 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to participate in the upcoming Jefferies 2017 Global Healthcare Conference in New York, NY.
IRIDEX's management is scheduled to present on Wednesday, June 7, 2017 at 4:30pm ET. Interested parties may access a live and archived webcast of the presentation at www.IRIDEX.com.
About IRIDEX
IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 70 independent distributors into over 100 countries. For further information, visit the IRIDEX website at http://www.iridex.com/.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/iridex-to-present-at-the-jefferies-2017-global-healthcare-conference-300463459.html
SOURCE IRIDEX Corporation
Investor Relations Contact, Lynn Pieper Lewis or Leigh Salvo, (415) 937-5404, investors@iridex.com
